Gender differences in drug bioequivalence: time to rethink practices.
about
Microphysiological modeling of the reproductive tract: a fertile endeavorGender differences in the adverse events' profile registered in seven observational studies of a wide gender-medicine (MetaGeM) project: the MetaGeM safety analysis.Sex and gender influences on pharmacological response: an overview.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets
P2860
Gender differences in drug bioequivalence: time to rethink practices.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Gender differences in drug bioequivalence: time to rethink practices.
@en
type
label
Gender differences in drug bioequivalence: time to rethink practices.
@en
prefLabel
Gender differences in drug bioequivalence: time to rethink practices.
@en
P2860
P356
P1476
Gender differences in drug bioequivalence: time to rethink practices
@en
P2093
P2860
P304
P356
10.1038/CLPT.2012.233
P407
P50
P577
2012-12-03T00:00:00Z